Clinical Care Considerations for COVID-19 Vaccination

National Center for Immunization and Respiratory Diseases. (2021). Clinical Care Considerations for COVID-19 Vaccination. Centers for Disease Control and Prevention.
This page provides updates on Advisory Committee on Immunization Practices recommendations and clinical considerations for managing adverse events for the use of Pfizer-BioNTech, Moderna, and Janssen/Johnson & Johnson COVID-19 vaccines for the prevention of COVID-19 in the U.S..
Rate: Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Enter your email address to receive important announcements and updates through the ASPR TRACIE Listserv.